Login / Signup

Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.

Toshio TakagiHironori FukudaTsunenori KondoHiroki IshiharaKazuhiko YoshidaHirohito KobayashiJunpei IizukaMasayoshi OkumiHideki IshidaKazunari Tanabe
Published in: Targeted oncology (2020)
CRP, NLR, and the number of metastatic organs were independent prognostic factors in IMDC intermediate-risk patients.
Keyphrases
  • prognostic factors
  • squamous cell carcinoma
  • small cell lung cancer
  • newly diagnosed
  • ejection fraction
  • stem cells
  • patient reported outcomes
  • patient reported